TxFlow Level Up: trade perps and earn up to 300 USDC at $4M volume. Until Nov 2 Join
Settings8H · net · $10k
LanguageThe language of the site
ThemeDark, or a soft blue-grey
FundingPeriod funding rates are shown in
UnitsPercent or basis points
CostsCount taker fees and slippage in Net
SizePosition per leg used for Net and slippage
ExchangesWhich exchanges to include everywhere
My profile →
My profile
Backtest 30d
LegExchangePriceFund. /8hEach paymentNext inOIVol 24hLev
LONG199.17+0.0050pay 0.0006% / 1h51m 54s$7K$327K5xLong Ondo Perps5% off
SHORT200.9000.0000% / 8h1h 51m$9.4M$5.4M50xShort MEXC
Price gap+0.869%48s
Funding gap−0.0050% /8h

The gap pays +$72 on $10k if it goes back to its 7d average, but funding costs $2 a day and eats that in about 48 days.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast
Funding+$3−0.0050% /8h now · paid +0.027% over the last 7D
Price—spread +0.869%48s now · prices read too far apart to compare
Costs−$700.700% of $10k · taker + slippage, in and out
Result—+ Points / potential airdropOndo Perps: points · farm boardneeds both prices read together

Price and funding

1h · history
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now+0.869%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

MRNA on 27 exchanges

lowest funding first

Before you open

1 ok · 5 to watch
  • Watch: Thin at this size27.4 / 6.0 bp
    At $10k entering Ondo Perps costs 27.4 bp, fee and slippage, 4.6× MEXC’s.
  • Note: Margin at max leverage$2,000 + $200
    Ondo Perps 5x, MEXC 50x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
  • Watch: Payment intervals differ1h / 8h
    Payments land at different times. Close right after the slower leg pays.
    Next 24h at the current rates, on $10k a leg: −$1.51Long Ondo Perps: 24 payments, −$1.51; short MEXC: 3 payments, $0.00.
  • Watch: Prices read 48 s apart+0.869% vs +0.144%
    Part of this gap may be the market moving.
  • Watch: Long leg is thinner$7K vs $9.4M OI
    Ondo Perps sets your exit cost. Check its book before closing.
  • OK: Points on a legOndo Perps points
    Volume here counts toward the points program.
  • Watch: KYCOndo Perps No · MEXC Yes
    KYC before trading since Feb 2026; unverified accounts see market data only.

Profit calculator

both legs, in and out
Position, each leg
Hold for
Orders
Price spread
Funding rate
Funding earned+0.0013%/8h × 21 periods+$2.69
Price spreadprices read too far apart to compare—
Slippage, 4 orderslive order books−$57.02
Fee Ondo Perps bp × 2 orders−$5.00
Fee MEXC bp × 2 orders−$8.00
Net · 7 days · $10k−$67.33
price spread not counted: prices read too far apart
Costs to cover0.700%Break-even182.1 days
Slippage: Ondo Perps: live order book, 55 min ago; MEXC: live order book, 6 min ago

Cost to enter

taker + slippage from mid, one side
BUY · LONGOndo Perps24.7927.4 bp−$2728.3 bp−$283doesn’t fitdoesn’t fit
SELL · SHORTMEXC0.256.0 bp−$6105.9 bp−$1,059192.7 bp−$19.3Kdoesn’t fit

Closing costs about the same again.

Alert

MRNA news

posts that mention MRNA, from every exchangeSearch all news →
10-25 09:09AZverseListingnew market mrna_usdt ($MRNA) seen by our collector
10-22 20:48ArcusOther$MRNA fell 25% today and was halted intraday on its primary exchange. The MRNA perp on Arcus kept trading through the halt. Traders could open, reduce, or close positions the entire time - as there is no halt state on Arcus perps. Markets run 24/7. Read more about Arcus RWA Perps here: @arcus_xyz on X ↗
10-22 19:35PhoenixOtherModerna falls after reported leak of Phase 3 melanoma vaccine data showing a 42% cut in recurrence risk, below Phase 2's 49%. $MRNA is trading at $195 on Phoenix, 24/7. @PhoenixTrade on X ↗
10-22 19:27BitgetOtherStay on top of fast-moving stock markets with Bitget Stock Perps. 📈📉 Here's the latest on Moderna $MRNA today ⤵️ @bitget on X ↗
10-20 17:07PhoenixOtherJUST IN: Moderna $MRNA is still climbing, up nearly 7% in the last 24 hours ahead of Saturday's Phase 3 cancer vaccine data at ESMO. @PhoenixTrade on X ↗
10-19 13:46PhoenixOtherJUST IN: $MRNA jumps 8.45% in anticipation of their Stage 3 cancer vaccine clinical trial results releasing on October 24. @PhoenixTrade on X ↗